| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $2.02 | $121.03 (0%) | π Add to cart |
| 90 | $1.97 | $181.55 $177.05 (2%) | π Add to cart |
| 120 | $1.88 | $242.07 $225.06 (7%) | π Add to cart |
| 180 | $1.71 | $363.10 $308.09 (15%) | π Add to cart |
| 270 | $1.59
Best per pill | $544.65 $430.12 (21%) | π Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.60 | $78.02 (0%) | π Add to cart |
| 60 | $2.27 | $156.04 $136.04 (13%) | π Add to cart |
| 90 | $2.16 | $234.07 $194.05 (17%) | π Add to cart |
| 120 | $2.09 | $312.09 $251.07 (20%) | π Add to cart |
| 180 | $2.04 | $468.13 $367.10 (22%) | π Add to cart |
| 270 | $2.00
Best per pill | $702.20 $540.15 (23%) | π Add to cart |
More info:
finast
Finast represents one of those interesting cases where a dietary supplement formulation actually bridges the gap between traditional herbal medicine and evidence-based clinical practice. When we first started working with this standardized saw palmetto extract, I’ll admit I was skeptical - the urology department had been burned by too many “natural prostate solutions” that turned out to be pharmacologically inert. ## 1. Introduction: What is Finast? Its Role in Modern Medicine
Avodart: Effective BPH Management and Hair Loss Prevention - Evidence-Based Review
Product Description: Avodart (dutasteride) is a prescription medication in the 5-alpha-reductase inhibitor class, specifically formulated as soft gelatin capsules containing 0.5 mg dutasteride. It’s primarily indicated for the management of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate, working through dual inhibition of both type 1 and type 2 isoforms of the 5-alpha-reductase enzyme system. Unlike single-enzyme inhibitors, this dual mechanism provides more complete suppression of dihydrotestosterone (DHT), the primary androgen responsible for prostate growth.
cardura
Cardura, known generically as doxazosin, is an alpha-1 adrenergic blocker primarily prescribed for managing hypertension and benign prostatic hyperplasia. It works by relaxing blood vessels and prostate/urethral smooth muscle. This monograph examines its clinical profile beyond standard prescribing information. 1. Introduction: What is Cardura? Its Role in Modern Medicine Cardura represents a selective alpha-1 adrenergic receptor antagonist that’s been workhorse therapy for decades. While newer agents emerge, doxazosin maintains relevance due to its dual-action mechanism - addressing both blood pressure and urinary symptoms simultaneously.
Dutas: Comprehensive DHT Suppression for BPH and Hair Loss - Evidence-Based Review
Dutasteride, marketed under brand names including Dutas, is a potent 5Ξ±-reductase inhibitor primarily used in clinical practice for managing benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern hair loss). Unlike finasteride which only inhibits type II 5Ξ±-reductase, dutasteride provides dual inhibition of both type I and type II isoforms, resulting in more comprehensive suppression of dihydrotestosterone (DHT) conversion from testosterone. This pharmaceutical agent represents a significant advancement in endocrine-targeted therapy, particularly for conditions driven by androgen-mediated tissue growth.
finpecia
Finpecia is the trade name for a pharmaceutical preparation containing finasteride 1mg, a synthetic 4-azasteroid compound that functions as a specific, competitive inhibitor of the Type II 5Ξ±-reductase enzyme. This enzyme is responsible for the intracellular conversion of testosterone to the more potent androgen dihydrotestosterone (DHT) in target tissues like the prostate gland and hair follicles. By inhibiting this conversion, Finpecia reduces serum and scalp DHT concentrations, which is the fundamental mechanism underpinning its primary clinical application: the treatment of male pattern hair loss (androgenetic alopecia).
flomax
Flomax, known generically as tamsulosin hydrochloride, represents a significant advancement in the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia. This alpha-1 adrenergic receptor antagonist specifically targets receptors in the prostate and bladder neck, facilitating smoother urine flow and reducing obstructive and irritative voiding symptoms. Its development marked a shift towards more selective pharmacological interventions, minimizing the cardiovascular side effects associated with non-selective alpha-blockers. Flomax: Targeted Relief for Benign Prostatic Hyperplasia Symptoms - Evidence-Based Review 1.
Himplasia: Comprehensive Prostate and Urinary Health Support - Evidence-Based Review
Himplasia represents one of those interesting interventions that sits right at the intersection of traditional herbal wisdom and modern clinical practice. It’s a proprietary polyherbal formulation developed specifically for benign prostatic hyperplasia (BPH), though we’ve found some surprising off-label applications over the years. What makes it particularly compelling is how it manages to address multiple pathological pathways simultaneously β something most single-compound pharmaceuticals struggle with. The formulation contains standardized extracts of several herbs that have been used traditionally for urinary and reproductive health, but what’s remarkable is how the combination seems to create synergistic effects that go beyond what you’d expect from simply adding up individual ingredient benefits.
Hytrin: Effective Symptom Relief for Benign Prostatic Hyperplasia - Evidence-Based Review
Terazosin hydrochloride - that’s the chemical name we’re really talking about here. It’s fascinating how this alpha-1 adrenergic blocker originally developed for hypertension found its true calling in benign prostatic hyperplasia. The way it selectively relaxes smooth muscle in the prostate and bladder neck while maintaining cardiovascular stability - that’s the kind of elegant pharmacology I appreciate. 1. Introduction: What is Hytrin? Its Role in Modern Medicine Hytrin represents one of the foundational alpha-blocker therapies that revolutionized BPH management back in the 1990s.
Minoxytop: Enhanced Hair Regrowth for Androgenetic Alopecia - Evidence-Based Review
Minoxytop represents a novel topical formulation combining 5% minoxidil with a proprietary blend of penetration enhancers and hair follicle activators, specifically designed to address the multifactorial nature of androgenetic alopecia. Unlike conventional minoxidil solutions that often cause scalp irritation and have limited efficacy in advanced cases, this medical device utilizes a nanoparticle-based delivery system to improve follicular targeting while minimizing systemic absorption. Having reviewed the preliminary clinical data and now used it in my practice for nearly 18 months, I can say it’s one of the more promising developments I’ve seen for pattern hair loss in the last decade.